Adrenoceptors in GtoPdb v. 2021.3
K Altosaar, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2021 - journals.ed.ac.uk
Adrenoceptors in GtoPdb v.2021.3 Page 1 IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2021.3
Adrenoceptors in GtoPdb v.2021.3 Katrin Altosaar1, Poornima Balaji2, Richard A. Bond3 …
Adrenoceptors in GtoPdb v.2021.3 Katrin Altosaar1, Poornima Balaji2, Richard A. Bond3 …
Adrenoceptors in GtoPdb v. 2023.1
JG Baker, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2023 - journals.ed.ac.uk
Adrenoceptors in GtoPdb v.2023.1 Page 1 IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2023.1
Adrenoceptors in GtoPdb v.2023.1 Jillian G. Baker1, Poornima Balaji2, Richard A. Bond3 …
Adrenoceptors in GtoPdb v.2023.1 Jillian G. Baker1, Poornima Balaji2, Richard A. Bond3 …
Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
K Altosaar, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2019 - journals.ed.ac.uk
Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Page 1
IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2019.4 …
IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2019.4 …
[HTML][HTML] Adrenoceptors—New roles for old players
Adrenoceptors have played a crucial role in the history of pharmacology. They were
essential parts of the work that led to the Nobel Prize in Physiology or Medicine to Sir James …
essential parts of the work that led to the Nobel Prize in Physiology or Medicine to Sir James …
Subclassification and nomenclature of α-and β-adrenoceptors
JP Hieble - Current topics in medicinal chemistry, 2007 - ingentaconnect.com
The subclassification of α-and β-adrenoceptors has resulted in many opportunities for drug
discovery. Important adrenoceptor targets include β2-agonists as bronchodilators, β1 or …
discovery. Important adrenoceptor targets include β2-agonists as bronchodilators, β1 or …
a-Adrenoceptor Agonists and Antagonists
JP Hieble, RR Ruffolo Jr - Receptor-based drug design, 1998 - taylorfrancis.com
Compounds interacting with the a-adrenoceptors, such as phenethylamines, imidazolines,
and ergot alkaloids, have been used as therapeutic agents for decades. However, many of …
and ergot alkaloids, have been used as therapeutic agents for decades. However, many of …
Cardiac β3‐adrenoceptors—A role in human pathophysiology?
E Arioglu‐Inan, G Kayki‐Mutlu… - British Journal of …, 2019 - Wiley Online Library
As β3‐adrenoceptors were first demonstrated to be expressed in adipose tissue they have
received much attention for their metabolic effects in obesity and diabetes. After the …
received much attention for their metabolic effects in obesity and diabetes. After the …
Recent advances in the identification of a 1-and a 2-adrenoceptor subtypes: therapeutic implications
JP Hieble, RR Ruffolo - Expert Opinion on Investigational Drugs, 1997 - Taylor & Francis
The cloning of multiple subtypes of both a1-and a2-adrenoceptors has renewed interest in
the therapeutic application of agents interacting with these receptors. Effort has primarily …
the therapeutic application of agents interacting with these receptors. Effort has primarily …
Why are there so many adrenoceptor subtypes?
G Mllligan, P Svoboda, CM Brown - Biochemical pharmacology, 1994 - Elsevier
* Molecular Pharmacology Group, Departments of Biochemistry and Pharmacology,
University of Glasgow, Glasgow G12 SQQ, Scotland, UK; $ Institute of Physiology, Czech …
University of Glasgow, Glasgow G12 SQQ, Scotland, UK; $ Institute of Physiology, Czech …
Challenges in β3-adrenoceptor agonist drug development
JRS Arch - Therapeutic advances in endocrinology and …, 2011 - journals.sagepub.com
Historical setting In the latter part of the 1970s and the early 1980s three pharmaceutical
companies were attempting to design drugs that would retain the thermogenic and …
companies were attempting to design drugs that would retain the thermogenic and …